| Title: |
Mechanisms of Resistance to Antibody–Drug Conjugates |
| Authors: |
Rachel Occhiogrosso Abelman; Bogang Wu; Laura M. Spring; Leif W. Ellisen; Aditya Bardia |
| Source: |
Cancers, Vol 15, Iss 4, p 1278 (2023) |
| Publisher Information: |
MDPI AG |
| Publication Year: |
2023 |
| Collection: |
Directory of Open Access Journals: DOAJ Articles |
| Subject Terms: |
antibody–drug conjugates; breast cancer; targeted therapies; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282 |
| Description: |
Antibody–drug conjugates (ADCs), with antibodies targeted against specific antigens linked to cytotoxic payloads, offer the opportunity for a more specific delivery of chemotherapy and other bioactive payloads to minimize side effects. First approved in the setting of HER2+ breast cancer, more recent ADCs have been developed for triple-negative breast cancer (TNBC) and, most recently, hormone receptor-positive (HR+) breast cancer. While antibody–drug conjugates have compared favorably against traditional chemotherapy in some settings, patients eventually progress on these therapies and require a change in treatment. Mechanisms to explain the resistance to ADCs are highly sought after, in hopes of developing next-line treatment options and expanding the therapeutic windows of existing therapies. These resistance mechanisms are categorized as follows: change in antigen expression, change in ADC processing and resistance, and efflux of the ADC payload. This paper reviews the recently published literature on these mechanisms as well as potential options to overcome these barriers. |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| Relation: |
https://www.mdpi.com/2072-6694/15/4/1278; https://doaj.org/toc/2072-6694; https://doaj.org/article/c2b71f029d384ad98cd7428e1f467e71 |
| DOI: |
10.3390/cancers15041278 |
| Availability: |
https://doi.org/10.3390/cancers15041278; https://doaj.org/article/c2b71f029d384ad98cd7428e1f467e71 |
| Accession Number: |
edsbas.53FAB170 |
| Database: |
BASE |